ÂÜÀòÂÒÂ×

Sergio is Chief Scientific Officer of BioVersys. His background spans from early drug discovery to early clinical development. He has conducted Phase 1 clinical studies and participated in later clinical studies and discussions with both the US FDA and EMA. He received his Laurea degree in Chemistry at the University of Rome, Italy in 1981 and, after a two-year postdoctoral fellowship at the Italian Research National Council, he moved to UNB, Canada, where he received his Ph.D. in 1987. In the same year, he started his career in the pharmaceutical industry as a medicinal chemist. In his almost 30 years of experience in major pharmaceutical companies and SMEs, Sergio has held positions such as Director of Medicinal Chemistry and International Project Leader in GSK, Head of Peptide Epitope Mimetics in Polyphor Ltd, and Head of Research and Scientific Communication in Arpida AG and has been part of the Board of Directors of Arpida A/S. As the founder of THOT consulting Sagl, a Swiss consulting firm, Sergio provided services in the Research and Development of anti-infectives and pharmaceutical drugs in general. He has held the position of CSO in C10 Pharma and Adenium Biotech, two Scandinavian biotech companies. Sergio has published extensively throughout his career and is a co-author of high-ranked scientific publications and patents in the field.